Screener
Aquestive Therapeutics, Inc. AQST Proprietary product revenue, net — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Manufacture and supply revenue | $11,911 | $9,583 | $20,704 | $16,776 |
| License and royalty revenue (a) | 1,326 | 839 | 6,721 | 1,629 |
| Co-development and research fees | 582 | 378 | 840 | 796 |
| Proprietary product revenue, net | — | (797) | — | (478) |
| Total revenues | $13,819 | $10,003 | $28,265 | $18,723 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s proprietary product revenue, net — revenue?
- Aquestive Therapeutics, Inc. (AQST) reported proprietary product revenue, net — revenue of $0 in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s proprietary product revenue, net — revenue changed year-over-year?
- Aquestive Therapeutics, Inc.'s proprietary product revenue, net — revenue increased by 100.0% year-over-year, from -$797K to $0.
- What does proprietary product revenue, net — revenue mean?
- This metric represents the net revenue generated from the sale of the company's internally developed and owned pharmaceutical products. It reflects the commercial success and market adoption of the firm's proprietary portfolio, excluding revenue derived from licensing or contract manufacturing arrangements. Tracking this figure helps investors evaluate the company's transition from a development-stage entity to a commercial-stage pharmaceutical business.
Ask your AI about Aquestive Therapeutics, Inc.'s proprietary product revenue, net — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude